State of Wisconsin Investment Board’s Cascadian Therapeutics, Inc. CASC Stock Holding History

State of Wisconsin Investment Board’s Portfolio CASC Stock Details CASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-28,000	Closed	-$104K	–	1482
2017 Q4	$104K	Hold	28,000	–	–	﹤0.01%	1425
2017 Q3	$115K	Hold	28,000	–	–	﹤0.01%	1435
2017 Q2	$104K	Buy	+28,000	New	+$111K	﹤0.01%	1442
2014 Q1	–	Sell	-225,000	Closed	-$2.38M	–	1355
2013 Q4	$2.38M	Hold	225,000	–	–	0.01%	1079
2013 Q3	$2.78M	Hold	225,000	–	–	0.01%	996
2013 Q2	$2.11M	Buy	+225,000	New	+$2.89M	0.01%	1089

State of Wisconsin Investment Board's CASC Position: Q1 2018 in Review

State of Wisconsin Investment Board sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 28,000 shares — an estimated $104K sold.

State of Wisconsin Investment Board first reported a position in CASC in Q2 2013 and held it in 6 quarters. The position peaked at $2.78M in Q3 2013. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

State of Wisconsin Investment Board reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
State of Wisconsin Investment Board sold 28,000 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $104K.
State of Wisconsin Investment Board first reported a position in Cascadian Therapeutics, Inc. in Q2 2013 and held it in 6 quarters.
State of Wisconsin Investment Board's Cascadian Therapeutics, Inc. position peaked at $2.78M in Q3 2013.
1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2018, filed 7 May 2018.